[The effect of different types of immunocorrective therapy on the clinical course of chronic myeloleukemia].
Influence of various patterns of immunocorrective therapy on clinical course of chronic myeloleukemia (CML) was studied. It was shown that combinations of drugs with different pharmacological effects provide more than 5-fold decrease in incidence of infection-related complications and promote rapid recovery from infections during antibacterial treatment.
Guseva
S A
SA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000276:immunology / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use; D011354:Prodigiozan / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use; D015002:Yeast, Dried / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001688:Biological Products; D004338:Drug Combinations; D010455:Peptides; D013949:Thymus Extracts; C003221:proper-myl; C036191:T-activin; D011354:Prodigiozan
Vliianie razlichnykh vidov immunokorrigiruiushcheĭ terapii na klinicheskoe techenie khronicheskogo mieloleĭkoza.